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ABSTRACT  The distribution  of cell surface  heparan  sulfate  proteoglycans  (HSPGs) was determined 
in rat liver by immunocytochemistry.  A polyclonal antibody was raised against HSPGs purified from 
rat liver microsomes which  specifically  immunoprecipitated  liver  membrane  HSPGs. It was shown 
to recognize both the heparin-releasable and membrane-intercalated form of membrane HSPGs and 
to recognize determinants on the core protein of these HSPGs. By immunocytochemistry membrane 
HSPGs were localized to hepatocytes. The distribution of HSPGs at the cell surface of the hepatocyte 
was restricted to the sinusoidal  domain  of the  plasmalemma; there was little or no staining of the 
lateral  or bile canalicular domains.  Intracellularly,  HSPGs were occasionally detected in cisternae  of 
the rough endoplasmic  reticulum  and were regularly found  in Golgi cisternae--usually  distributed 
across  the  entire  Golgi  stack.  HSPGs were  also  localized  in  some  endosomes,  lysosomes,  and 
cytoplasmic vesicles of hepatocytes. We conclude that the HSPGs recognized by this antibody have 
a restricted distribution  in rat liver:  they are largely confined to the sinusoidal  plasmalemmal  domain 
and to biosynthetic and endocytic compartments of hepatocytes. 
Heparan sulfate proteoglycans (HSPGs) ~ are widely distrib- 
uted in mammalian tissues and cell cultures. They have been 
found  in  association  with  cell  surfaces  (1-5),  intracellular 
organdies (6,  7), and extracellular matrices (especially base- 
ment membranes) (8-11), and have been proposed to partic- 
ipate in a  variety of functions such  as cell-cell  interactions 
(12),  cell  migration (13), and cell adhesion (14,  15). HSPGs 
isolated  from  different  sources  have  distinct  structures  in 
terms of their overall size (70-400 kD) and the size of their 
glycosaminoglycan chains (14-70 kD). 
One of the best characterized populations of HSPGs are 
those isolated from rat liver membranes (3, 15). These HSPGs 
are relatively small (75 kD) and consist of a core protein with 
about four attached heparan sulfate (HS) side chains (14 kD). 
Three  forms of HSPG  have  been  purified  from  rat  liver 
membranes (3,  16) and from primary hepatocyte cultures (15, 
17)--one that behaves as a peripheral membrane protein in 
that  it  can  be displaced  from cells  by exogenous  heparin, 
another that behaves as an integral membrane protein in that 
Abbreviations used in this paper."  ER, endoplasmic reticulum; HS, 
heparan sulfate; HSPGs, heparan sulfate proteoglycans; PMs, plasma 
membrane fractions. 
its core protein is intercalated into the lipid bilayer, and a 
third form, recently characterized, which consists of HS oli- 
gosaccharides and is believed to be associated with lysosomes 
(Kj611en, L., H. Pertofi, A. Oldberg, M. H66k, submitted for 
publication).  The  heparin-displacable and membrane-inter- 
calated forms are known to be present in rat liver microsomal 
and plasma membrane fractions, but their precise localization 
in rat liver in situ is unknown. 
In this study, an antibody was generated against rat liver 
membrane HSPGs and used to determine the distribution of 
these HSPGs in rat liver. 
MATERIALS  AND  METHODS 
Materials:  Molecular weight standards for SDS  PAGE and Sepharose 
4B-Protein A beads were obtained from Pharmacia Fine Chemicals (Uppsala, 
Sweden). lodobeads were obtained from Pierce Chemical Co. (Rockford, IL), 
and Na[t2~I] was obtained from Amersham Corp. (Arlington Heights, IL). Fab 
fragments of sheep anti-rabbit IgG conjugated to horseradish peroxidase were 
obtained from the Institute Pasteur Productions (Marnes La Coquette, France). 
3,3 diaminobenzidine and pepstatin A were  obtained from Sigma Chemical 
Co. (St. Louis, MO).  Fluorescein isothiocyanate-conjugated rabbit anti-goat 
IgG and goat anti-rabbit F(ab')2 were obtained from Cappel Laboratories,  Inc. 
(Cochranville,  PA), and l0 nm colloidal gold coupled to sheep anti-rabbit IgG 
was obtained from Janssen Life Science  Products (Piscataway,  N  J).  Platelet- 
derived heparitinasc was prepared as previously described  (3). 
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microsomes  by gel chromatography, ion exchange  chromatography, and density 
gradient ultracentrifugation (3). Purity was assessed by enzymatic degradation. 
analytical centrifugation, and amino acid analysis (3). An amount correspond- 
ing to 25 ug protein (in  100 #l) was emulsified in complete Freund's adjuvant 
(100 ul) and injected (50-~1 aliquots) into the popliteal lymph nodes of a rabbit. 
Booster  injections in incomplete Freund's adjuvant were given twice at 2-wk 
intervals.  The rabbit  was bled  10, 20, and 30 d after the last injection,  and the 
antiserum was screened  for reactivity  to  HSPGs by immunoprecipitation as 
described  below,  lgO was isolated  from the antiserum by affinity chromatog- 
raphy on Protein  A-Sepharose (l 8). 
Preparation of  1251-HSPGs and 12sI-PMs:  Plasma  membrane 
fractions (PMs) (19) and membrane HSPGs (16) were prepared from rat livers 
as detailed previously,  and radioiodinated by the Chloramine T method using 
Iodobeads.  ~251-PMs were  solubilized  in  I%  Triton  X-100,  in  phosphate- 
buffered saline (PBS). 
Preparation  of [35S]Sulfate I-ISPG:  Primary cultures of rat hepa- 
tocytes were radiolabeled  with 100 t~Ci/ml of [3~S]sulfate for 24 h as previously 
described  (15). Protease  inhibitors, phenylmethylsulfonyl  fluoride  (l  mM), n- 
ethylmaleimide  (2 mM), EDTA (2 mM), and pepstatin ( l0 t~g/ml), were present 
in all buffers used for isolation of HSPGs. The radiolabeled  cells were incubated 
with 0.5 mg/ml heparin to displace  receptor-bound HSPGs (15) which were 
collected, and the cells were further incubated with 1% Triton X-100 in 0.05M 
Tris buffer (pH  8.0)  for  30  min at 25"C  to  release  membrane-intercalated 
HSPGs and HS polysaccharide.  After centrifugation (to pellet  unsolubilized 
material),  HSPGs were purified  from the detergent extract and from heparin- 
displaced  fractions by DEAE-ion exchange chromatography and gel chroma- 
tography on Sepharose CL-4B (16).  The membrane-intercalated HSPGs and 
HS oligosaccharide  are separated in the latter step. 
Immunoprecipitation:  ~251-HSPGs  (3 #g protein) or ~2~I-PMs  (2 #g) 
were incubated at 4oc overnight with IO0 #l of normal or immune rabbit serum 
in PBS containing 0.1% Triton X-100 and 5 mg/ml bovine serum albumin in 
a total volume of 1 ml. 3~S-HSPGs or HS (5,000 clam) were incubated under 
similar conditions with varying amounts of IgG. After addition of 100 #l of a 
l/1  suspension of Protein A-Sepharose  in PBS and further incubation for l h 
at room temperature, the beads were pelleted  by centrifugation, washed with 
4 x  I ml of PBS containing 0.5 M NaCl and 0.1% Triton X-100, and assayed 
for ~251- or 35S-radioactivity. 
SDS  PAGE:  Immunoprecipitates obtained  from  J25I-labeled samples 
were solubilized  and analyzed on 7-15% polyacrylamide gradient gels with a 
4.8%  stacking gel  in  a  Maisel  buffer system as  described  by  BIobel and 
Dobberstein (20). After fixation in  12% trichloroacetic  acid, gels were stained 
with Coomassie Blue, and autoradiographed using Kodak X-Omat AR films. 
Exposure was at -700C for 3 d. 
Preparation of Tissue for Immunocytochemistry:  Procedures 
used for the fixation  and incubation of rat liver were as described  in an earlier 
paper (21). In brief, fixation  was initiated by perfusion with periodate-lysine- 
paraformaldehyde, and blocks of  tissue were excised and immersed in the same 
fixative for an additional ,1-6 h at 25"C. 
Immunofluorescence:  Frozen sections (0.5 um) were prepared  from 
periodate-lysine-paraformaldehyde-fixed  rat liver on a Reichert Ultracut OMU- 
4 ultramicrotome equipped with a cryoattachment. Sections were mounted on 
glass slides and incubated sequentially  in (a)  normal rabbit  serum or anti- 
HSPG antiserum or IgG, (b) fluorescein isothiocyanate  goat anti-rabbit F(ab')2, 
and (c) fluorescein isothiocyanate rabbit anti-goat IgG (to enhance the fluores- 
cent  signal);  sections were  then  examined  in  a  Zeiss Photomicroscope  II 
equipped with epifluorescence. 
Immunoperoxidase:  Procedures used  for  indirect  immunoperoxi- 
dasc staining were given elsewhere  (21-23). In brief, cryostat sections (15-20 
urn) were  prepared  from  periodate-lysine-paraformaldehyde-fixed liver  and 
incubated in (a) normal rabbit or immune serum (diluted  Ys) or IgG (3 #g/ml) 
for 12-16 h and (b) peroxidase-conjugated  sheep anti-rabbit Fab (2 h). Sections 
were then fixed in  1.5% glutaraldehyde,  incubated in diaminobenzidine me- 
dium, postfixed in ferrocyanide-reduced OsO4 and embedded in Epon. 
Immunogold:  Cryostat sections were incubated in immune or preim- 
mune serum as above and then in sheep anti-rabbit-gold  conjugate (24--48 h), 
postfixed in  1% OsO4 in acetate-veronal  buffer,  stained in block with uranyl 
acetate,  and embedded in Epon. 
RESULTS 
Immunoprecipitation of 1251-HSPGs 
When  fractions of ~251-HSPGs purified from rat liver plasma 
membranes  (composed  of a  mixture  of membrane-interca- 
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lated and heparin-releasable HSPGs)  were incubated with the 
antibody,  30%  of the  ~2~I counts  were  precipitated,  whereas 
only  2%  were  precipitated  with  control  serum.  When  PMs 
were  iodinated  and  the  solubilized  proteins  were  used  for 
immunoprecipitation,  only background  amounts  of radioac- 
tivity were precipitated with either immune  or normal  rabbit 
serum.  Previous  experiments  have  established  that  this  is 
because  no  detectable  amount  of  ~25I-radioactivity  is  incor- 
porated into HSPGs  when  intact PMs  are iodinated (Kjrllen, 
L., and M.  H66k,  unpublished  observations). When  ~25I-PMs 
and 125I-HSPGs (constituting 40% of the total protein or  10% 
of the total  t25I-radioactivity) were mixed, the precipitation of 
~25I-HSPGs was as efficient as with  ~2SI-HSPGs alone, indicat- 
ing that  plasma  membrane  proteins do  not  inhibit antibody 
binding. 
Digestion of the  ~25I-HSPGs with a  purified  platelet hepar- 
itinase (3) and the presence of unlabeled heparin did not affect 
the amount  of HSPGs  precipitated,  suggesting that the anti- 
body  recognizes determinants  on  the  core  protein--not  the 
polysaccharide chains--of  these HSPGs. 
By SDS PAGE  (Fig.  l), immunoprecipitates  obtained from 
t25I-HSPGs  or  a  mixture  of  the  latter  and  t25I-PMs  with 
[-IGURE  ]  (A)  Samples of 12~l-labeled  rat liver  plasma membrane 
fractions  (usI-PMs)  (80,000  cpm;  lane  I)  and  purified  12SI-HSPGs 
(20,000 cpm; lane 2) were separated by SDS  PAGE and exposed 
for  autoradiography.  ~2sI-PMs contain  numerous  labeled  protein 
bands, and ~2SI-HSPGs  appear as a typical broad band concentrated 
at the interface of the stacking and running gels. (B) Autoradiograms 
of immunoprecipitates obtained when anti-HSPG  serum (lanes  3- 
5)  or  normal  rabbit serum  (lanes  6-8)  were  incubated  with  ~2Sl- 
HSPGs alone (lanes 3 and 6), with a mixture of 12SI-HSPGs and ~2sl- 
PMs  (lanes  4  and  7),  or  with  ~251-PMs alone  (lanes  5  and  8).  A 
smeared band at the top of the gel corresponding to  HSPGs was 
precipitated by the anti-HSPG serum from ~2SI-HSPGs (lane 3) and 
from the mixture of ~2SI-HSPGs and 12SI-PMs (lane 4), but not from 
12sI-PMs alone  (lane  5).  No  such  bands  were  precipitated  with 
normal rabbit serum (lanes 6  8). The narrow band at the top of the 
stacking gel (lanes 5, 7, and 8) is considered to be nonspecific since 
it is present with both normal and immune sera. immune serum were identical to that of  purified 125I-HSPGs-- 
i.e., the labeled material accumulated at the interface between 
the stacking and running gel, and no other protein bands were 
precipitated. (Compare lanes 2, 3, and 4). No labeled material 
was precipitated from 125I-HSPGs with normal rabbit serum 
(lanes 6-8) or from '25I-PMs with immune serum (lane 5). 
Enzyme-linked immunosorbent assays analyses showed no 
reactivity of the antiserum with laminin, fibronectin, or Type 
IV collagen (data not shown). 
Collectively, these data indicate that the antiserum gener- 
ated against liver membrane HSPGs recognizes the core pro- 
tein  of membrane HSPGs but  does not  react with plasma 
membrane  proteins  or  with  common  extracellular  matrix 
constituents. 
Immunoprecipitation of 35S-HSPGs 
To  establish  which  forms  of cell-associated  HSPGs  are 
recognized by the antibody, we carried out immunoprecipi- 
tations with 35S-HSPGs isolated from primary cultures of rat 
hepatocytes. Up to  50%  of the  membrane-intercalated 35S- 
HSPGs but only -  12% of the heparin-releasable 35S-HSPGs 
was  precipitated  by  the  antibody  (Fig.  2).  There  was  no 
reactivity with the 355-HS oligosaccharide (Fig.  2) as antigen 
or when  the  antiserum was substituted with  normal rabbit 
serum (not shown). 
Localization of HSPGs in Rat Liver 
When 0.5-#m ultracryomicrotome sections were incubated 
with anti-HSPG serum or IgG for immunofluorescence, stain- 
ing was seen around the hepatic sinsuoids (Fig. 3 A). A similar 
distribution of reaction product was seen in 0.5-um sections 
of plastic-embedded  immunoperoxidase  preparations  (Fig. 
3B). Some foci ofintracellular staining were also seen in the 
hepatocyte cytoplasm in the latter. No staining was detected 
in sections similarly reacted with normal rabbit serum. 
When immunoperoxidase preparations were examined by 
electron microscopy (Figs.  4-6 and 8-9), it was evident that 
the staining seen around the  hepatic sinusoids by light mi- 
croscopy was due to its presence on the hepatocyte cell surface 
facing the space of Disse (Figs.  4 and 8), and that there was 
little staining of the endothelial and Kupffer cell surfaces. In 
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FIGURE 2  Different forms  of 35S-HSPGs or  HS  oligosaccharides 
(5,000 cpm) were incubated with indicated amounts of anti-HSPG 
IgG. After incubation with protein A-Sepharose, the percentage of 
3SS-radioactivity bound to the gel was determined. Precipitation of 
intercalated membrane 35S-HSPGs  (O) is more efficient than that of 
peripheral (heparin-released)  35S-HSPGs (A). The HS-oligosaccha- 
ride (&) is not recognized. 
FIGURE 3  Localization of HSPGs in  rat  liver by  immunofluores- 
cence  (A)  (0.5-#m  ultracryomicrotome section)  and by  immuno- 
peroxidase (B) (0.5-~,m plastic-embedded section). Staining is con- 
centrated  around the hepatic sinusoids  (S)  in  both  preparations. 
Staining is also seen intracellularly (arrows) in sites corresponding 
to the location of Golgi complexes (see Figs. 4 and 5). (A)  x  150; 
(B) x  98. 
hepatocytes, a continuous layer of reaction product was pres- 
ent all along the microvilli and coated pits at the sinusoidal 
domain, but there was little or no staining of the lateral or 
bile canalicular plasmalemmal domains (Figs. 4 and 5). The 
same concentration  of HSPGs on the  sinusoidal  surface of 
hepatocytes was seen in sections reacted by the immunogold 
procedure,--i.e, gold particles were present in large numbers 
on the sinusoidal cell surface of hepatocytes (Fig.  7), but few 
were seen on endothelial or Kupffer cells or on the lateral or 
bile canalicular surfaces of hepatocytes. 
Within the hepatocyte, staining was present in Golgi and 
endoplasmic reticulum (ER) cisternae (Figs.  4-6) as well as 
in some cytoplasmic vesicles (Fig.  5) and in some endosomes 
and lysosomes (Figs.  8-9). The most regular and prominent 
site  of intracellular  staining  was the  Golgi  complex where 
reaction product was consistently found in the stacked cister- 
nae (Figs.  5-6). In the majority of cases all the cisternae in a 
given stack were stained, but there was no staining of GERL- 
like structures.  Staining  of the  rough  ER  was less  frequent 
and more patchy; when present, reaction product was typi- 
cally concentrated at the tips of the reactive cisternae (Fig. 5). 
The number of stained endosomes and lysosomes was quite 
variable from one cell to another. 
In controls incubated with normal rabbit serum, no reac- 
tion product was detected in any location. 
RAPID COMMUNICATIONS  977 FIGURES 4-6  Electron micrographs  demonstrating the localization of HSPGs in rat liver by immunoperoxidase. Fig. 4 is a low 
magnification view of a hepatocyte showing staining of the sinusoidal domain of the hepatocyte cell membrane (cm) facing the 
sinusoid  (Sin).  The lateral (cm') domain (between the sinusoid and the bile canaliculus  [BC]) and the bile canalicular domain 
(facing the bile canaliculus) of the hepatocyte show little or no staining. Staining is also present intracellularly in several Golgi 
complexes (G).  Figs. 5 and 6 illustrate the localization of HSPGs in the stacked Golgi cisternae (Gc). Reaction product is seen 
distributed across all of the cisternae in each stack. It is not present in a GERL- or lysosome-like  structure  (Fig. 6, arrow). Also 
illustrated  (Fig. 5) is the presence of reaction product at the tip of an ER cisternae (er) and in several cytoplasmic  vesicles (ve), 
and  the absence of reaction product from the bile canalicular  (BC) and  lateral (cm')  domains of the plasmalemma. (Fig. 4) 
x  13,500; (Fig. 5) x  39,000; (Fig. 6) x  50,000. 
DISCUSSION 
In this study,  we produced  a  specific antibody to  rat  liver 
membrane HSPGs and used it to determine the localization 
of HSPGs  in  the  rat  liver.  Immunoprecipitation  analyses 
established that the antibody generated specifically recognizes 
HSPGs purified from rat liver plasma membrane fractions, 
and  it  preferentially recognizes  the  membrane-intercalated 
form of HSPGs. It was concluded that the antibody recognizes 
determinants on the core protein but not on the polysaccha- 
ride chains of these HSPGs because it does not react with HS 
oligosaccharide  and  because  release  of the  polysaccharide 
chains (by heparitinase digestion) did not affect immunopre- 
cipitation. 
By immunocytoehemistry, we found that the HSPGs ree- 
978  RAPID  COMMUNICATIONS FIGURE  7  Portion of a  hepatocyte from  a  section  incubated with  anti-HSPG  IgG  and  labeled by an  indirect immunogold 
procedure. Clumps of gold particles are concentrated on the microvilli (my) at the sinusoidal  domain of the hepatocyte and few 
are bound to the endothelial (en) plasmalemma, x  40,000. 
ognized by this antibody are restricted in their distribution to 
hepatocytes where they are concentrated along the sinusoidal 
domain of the plasmalemma. In addition, they are regularly 
found intraceUularly associated with Golgi cisternae and some 
rough ER cisternae, as well as with some of the cytoplasmic 
vesicles, endosomes, and lysosomes. 
Previous biochemical results established that  HSPGs are 
present in rat liver plasma membrane fractions (3) prepared 
by the method of Ray (19).  Such fractions are assumed to be 
derived primarily from the  bile canalicular and  lateral do- 
mains of the hepatocyte plasmalemma, but they also contain 
variable amounts of sinusoidal plasma membrane and other 
(e.g.,  Golgi) membranes as well (24).  The present immuno- 
cytochemical results confirm that HSPGs are associated with 
the hepatocyte plasmalemma, and demonstrate further that 
(a) they are largely restricted to the sinusoidal plasmalemmal 
domain of this cell,  (b) they are missing or present in very 
low concentrations  on  the  lateral  and  bile  canalicular do- 
mains, and (c) they are not restricted to the plasma membrane 
but are found in intracellular compartments of hepatocytes 
as well. 
At present there are a  number of examples of membrane 
constituents which are highly concentrated or located exclu- 
sively on a particular domain of  the hepatocyte plasmalemma. 
Some membrane constituents,  such as receptors for insulin 
(25), asialoglycoproteins (26), and mannose-6-phosphate (21) 
are found mainly if not exclusively on the sinusoidal domain, 
whereas others, such as (Na÷K+)-ATPase (27) and adenylate 
cyclase  (24)  are  found  on  both  the  sinusoidal  and  lateral 
domains. Still  other components, such as phosphatases and 
leucine aminopeptidase (24),  and three membrane glycopro- 
teins (105,  110, and  160 kD) of unknown function (28),  are 
restricted to the bile canalicular domain. 
The function of the HSPGs concentrated at the  vascular 
surface of the hepatocyte is not known. Previous studies have 
demonstrated that HSPGs on the surfaces of endothelial cells, 
which,  like the sinusoidal surface of the  hepatocyte are ex- 
posed to the blood plasma, are able to bind molecules from 
the circulation such as lipoprotein lipase (29) and antithrom- 
bin  (30).  A  role for heparin in  modulating binding of low 
density lipoproteins to their receptors has also been postulated 
(31). 
The HSPGs present within the ER and Golgi cisternae of 
hepatocytes  most  likely  represent  a  biosynthetic  pool  of 
HSPGs destined  for the  cell surface since it is known that 
newly synthesized proteoglycans, like glycoproteins, are seg- 
regated in the rough ER and transported to the Golgi complex 
where they undergo extensive posttranslational modification 
(e.g., glycosylation and sulfation) (32).  The HSPGs detected 
in endosomes and lysosomes could be destined for degrada- 
tion or could be in transit during recycling (33).  The vesicles 
located near the cell surface in which we detected HSPGs are 
probably involved in the transport of HSPGs either from the 
Golgi to the cell surface or from the latter to endosomes and 
lysosomes. However, the possibility that the HSPGs are inte- 
gral components of the membranes of these compartments 
cannot be ruled out at present. Kinetic and cell fractionation 
studies  are  required  to determine  the  relationship  (biosyn- 
thetic, degradative, recycling?) between the HSPGs detected 
in these different organelles. 
The antibody raised against liver HSPGs appears to recog- 
nize plasma membrane-associated HSPGs from tissues other 
than  liver because  it  stains  plasma  membranes of kidney 
epithelia and endothelia (34) and of cultured fibroblasts (35). 
However, it does not recognize HSPGs associated with base- 
ment membranes because it does not stain basement mem- 
R^P~o COMMUNIC^T~ONS  979 FIGURES  8  and  9  Localization of  HSPG  in  endosomes and  lyso- 
somes by immunoperoxidase. In Fig. 8, reaction product is seen in 
an  endosome  (en)--with  a  tubular  connection  (arrow)--Iocated 
near  the  sinusoidal  cell  surface.  The  sinusoidal  domain  of  the 
plasmalemma (cm)  is  also  stained.  In  Fig.  9,  reaction  produ~:t  is 
seen in a presumptive endosome (en) and in a lysosome (/y). (Fig. 
8) x  46,500; (Fig. 9) x  22,000. 
branes in kidney and other tissues (34). Recently an antibody 
was raised against HSPGs purified from rat kidney glomeruli 
that stains basement membranes but does not stain epithelial 
or endothelial plasma membranes in the kidney (36) and in 
other  tissues  surveyed,  including  rat  liver.  These  findings 
suggest that the plasma membrane HSPGs are antigenically 
distinct  from  the  basement  membrane-associated  HSPGs. 
Further work in progress using anti-HSPG antibodies is aimed 
at determining the relationship between these two populations 
of HSPG. 
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